A Death-Promoting Role for Extracellular Signal-Regulated Kinase
Open Access
- 26 June 2006
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 319 (3), 991-997
- https://doi.org/10.1124/jpet.106.107367
Abstract
Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), which are members of the mitogen-activated protein kinase superfamily, have been well characterized and are known to be involved in cell survival; however, recent evidence suggests that the activation of ERK1/2 also contributes to cell death in some cell types and organs under certain conditions. For example, ERK1/2 is activated in neuronal and renal epithelial cells upon exposure to oxidative stress and toxicants and deprivation of growth factors, and inhibition of the ERK pathway blocks apoptosis. ERK activation also occurs in animal models of ischemia- and trauma-induced brain injury and cisplatin-induced renal injury, and inactivation of ERK reduces the extent of tissue damage. In some studies, ERK has been implicated in apoptotic events upstream of mitochondrial cytochrome c release, whereas other studies have suggested the converse that ERK acts downstream of mitochondrial events and upstream of caspase-3 activation. ERK also can contribute to cell death through the suppression of the antiapoptotic signaling molecule Akt. Here we summarize the evidence and mechanism of ERK-induced apoptosis in both cell culture and in animal models.Keywords
This publication has 85 references indexed in Scilit:
- The survival kinases Akt and Pim as potential pharmacological targetsJournal of Clinical Investigation, 2005
- CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2Cellular Signalling, 2005
- STRESS signaling pathways that modulate cardiac myocyte apoptosisJournal of Molecular and Cellular Cardiology, 2005
- Counting on mitogen-activated protein kinases—ERKs 3, 4, 5, 6, 7 and 8Cellular Signalling, 2004
- An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosisBiochemical Pharmacology, 2004
- Mechanisms of caspase activationCurrent Opinion in Cell Biology, 2003
- MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemiaProceedings of the National Academy of Sciences, 1999
- Inflammatory Mediators and Stroke: New Opportunities for Novel TherapeuticsJournal of Cerebral Blood Flow & Metabolism, 1999
- Hydrogen Peroxide Activation of Multiple Mitogen‐Activated Protein Kinases in an Oligodendrocyte Cell LineJournal of Neurochemistry, 1999
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995